A ray of hope: Several corona virus vaccines enter human trials

A ray of hope: Several corona virus vaccines enter human trials

The viral outbreak corona virus or COVID-19 has been classified as a pandemic. The world wasn’t prepared for a disaster of such magnitude, this unpreparedness resulted in many casualties.

This virus has claimed the lives of thousands and over a million people have been infected as of yet. It doesn’t end there as thousands of employees were laid off, stock markets have crashed, inflation is on the rise and the whole world is in lock down. 


Doctors are asking people to maintain a physical distance of 6 feet, wash their hands and don’t leave home in hopes of halting the spread of corona virus.

Those who are infected are instructed to quarantine themselves, stay hydrated and take fever reducers, as there is no cure yet.


Scientists around the globe are tirelessly working to find a vaccine to cure the viral outbreak. There is a little hope as few vaccines have been approved by the FDA to enter the human trial segment. 

NOVAVAX a company working on COVID-19 said its vaccine had stimulated a powerful immune response in lab and animal experiments, producing antibodies that could fight off the coronavirus.

The health care behemoth Johnson & Johnson expects to start the clinical trials of their vaccine in September. Biotech company Moderna’s vaccine is already in a clinical trial.

Another vaccine, developed by Inovio Pharmaceuticals, was administered to the first adult volunteers. Experimental vaccines developed by researchers at the University of Pittsburgh and Baylor College of Medicine in Houston are also waiting for permission from the Food and Drug Administration to begin testing in people.


For now, the first stage of clinical trials for each potential coronavirus vaccine must focus on how safe or toxic the vaccine may be at different dose levels.

Researchers will collect the medical histories of volunteers participating in the trials and track their antibody levels, liver enzymes, and other indicators of emerging side effects.

“If everything looks good and the vaccine appears to be safe, then we’ll go on to trials with much bigger numbers and look at the vaccine efficacy,” said Dr. John Ervin, who is leading the Inovio clinical trial in Kansas City, Mo.


Doctors and scientists are building out a road map for how we fight with this pandemic as a country & society for the next two or three years. That’s roughly the same time frame that we saw for the 1918 flu pandemic and that’s probably likely for COVID-19. 


Please enter your comment!
Please enter your name here